FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like Novartis Poised for Growth as CEO Hands Baton to Successor January 23, 2018 Apotex CEO Abruptly Resigns Amid Allegations of Trade Secret Leaks January 28, 2018 Eagle Pharma To Discuss First Quarter 2017 Financial Results On May 8, 2017 April 24, 2017
